{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:58:08Z","timestamp":1792652288358,"version":"4.5.0"},"reference-count":64,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"12","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest. Ophthalmol. Vis. Sci."],"published-print":{"date-parts":[[2022,11,1]]},"DOI":"10.1167\/iovs.63.12.2","type":"journal-article","created":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T11:31:15Z","timestamp":1667302275000},"page":"2","source":"Crossref","is-referenced-by-count":11,"title":["Combination of AIBP, apoA-I, and Aflibercept Overcomes Anti-VEGF Resistance in Neovascular AMD by Inhibiting Arteriolar Choroidal Neovascularization"],"prefix":"10.1167","volume":"63","author":[{"given":"Zhao","family":"Zhang","sequence":"first","affiliation":[{"name":"Cullen Eye Institute, Baylor College of Medicine, Houston, Texas, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan M.","family":"Shen","sequence":"additional","affiliation":[{"name":"Cullen Eye Institute, Baylor College of Medicine, Houston, Texas, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingbin","family":"Fu","sequence":"additional","affiliation":[{"name":"Cullen Eye Institute, Baylor College of Medicine, Houston, Texas, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"key":"bib1","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","article-title":"Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis","volume":"2","author":"Wong","year":"2014","journal-title":"Lancet Glob Health"},{"key":"bib2","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/0039-6257(88)90052-5","article-title":"Age-related macular degeneration","volume":"32","author":"Bressler","year":"1988","journal-title":"Surv Ophthalmol"},{"key":"bib3","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1016\/j.ophtha.2016.03.045","article-title":"Five-Year Outcomes with Anti-Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration: The Comparison of Age-Related Macular Degeneration Treatments Trials","volume":"123","author":"Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group, Maguire","year":"2016","journal-title":"Ophthalmology"},{"key":"bib4","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.2147\/DDDT","article-title":"Resistance to anti-VEGF therapy in neovascular age-related macular degeneration: a comprehensive review","volume":"10","author":"Yang","year":"2016","journal-title":"Drug Des Devel Ther"},{"key":"bib5","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1016\/j.ophtha.2013.03.046","article-title":"Seven-year outcomes in ranibizumab-treated patients in ANCHOR, MARINA, and HORIZON: a multicenter cohort study (SEVEN-UP)","volume":"120","author":"Rofagha","year":"2013","journal-title":"Ophthalmology"},{"key":"bib6","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1136\/bjophthalmol-2013-303513","article-title":"Non-responders to treatment with antagonists of vascular endothelial growth factor in age-related macular degeneration","volume":"97","author":"Krebs","year":"2013","journal-title":"Br J Ophthalmol"},{"key":"bib7","doi-asserted-by":"publisher","first-page":"100906","DOI":"10.1016\/j.preteyeres.2020.100906","article-title":"Incomplete response to Anti-VEGF therapy in neovascular AMD: Exploring disease mechanisms and therapeutic opportunities","volume":"82","author":"Mettu","year":"2021","journal-title":"Prog Retin Eye Res"},{"key":"bib8","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.ophtha.2010.07.011","article-title":"Characteristics of Patients Losing Vision after 2 Years of Monthly Dosing in the Phase III Ranibizumab Clinical Trials","volume":"118","author":"Rosenfeld","year":"2011","journal-title":"Ophthalmology"},{"key":"bib9","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ajo.2015.04.012","article-title":"Optical Coherence Tomography Angiography Signs of Vascular Abnormalization With Antiangiogenic Therapy for Choroidal Neovascularization","volume":"160","author":"Spaide","year":"2015","journal-title":"Am J Ophthalmol"},{"key":"bib10","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1016\/j.ophtha.2012.09.006","article-title":"Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration","volume":"119","author":"Heier","year":"2012","journal-title":"Ophthalmology"},{"key":"bib11","doi-asserted-by":"publisher","first-page":"e310","DOI":"10.1371\/journal.pmed.0030310","article-title":"Macrophages inhibit neovascularization in a murine model of age-related macular degeneration","volume":"3","author":"Apte","year":"2006","journal-title":"PLoS Med"},{"key":"bib12","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1136\/bjo.2009.165563","article-title":"Bruch's membrane and choroidal macrophages in early and advanced age-related macular degeneration","volume":"94","author":"Cherepanoff","year":"2010","journal-title":"Br J Ophthalmol"},{"key":"bib13","doi-asserted-by":"publisher","first-page":"3586","DOI":"10.1167\/iovs.03-0038","article-title":"Macrophage depletion diminishes lesion size and severity in experimental choroidal neovascularization","volume":"44","author":"Espinosa-Heidmann","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib14","first-page":"119","article-title":"Macrophage and retinal pigment epithelium expression of angiogenic cytokines in choroidal neovascularization","volume":"8","author":"Grossniklaus","year":"2002","journal-title":"Mol Vis"},{"key":"bib15","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.neurobiolaging.2016.11.018","article-title":"Proangiogenic characteristics of activated macrophages from patients with age-related macular degeneration","volume":"51","author":"Hagbi-Levi","year":"2017","journal-title":"Neurobiol Aging"},{"issue":"Pt 4","key":"bib16","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/eye.1990.86","article-title":"Macrophages related to Bruch's membrane in age-related macular degeneration","volume":"4","author":"Killingsworth","year":"1990","journal-title":"Eye (Lond)"},{"key":"bib17","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/S0161-6420(93)31657-X","article-title":"Well-defined subfoveal choroidal neovascular membranes in age-related macular degeneration","volume":"100","author":"Lopez","year":"1993","journal-title":"Ophthalmology"},{"key":"bib18","doi-asserted-by":"publisher","first-page":"3578","DOI":"10.1167\/iovs.03-0097","article-title":"Macrophage depletion inhibits experimental choroidal neovascularization","volume":"44","author":"Sakurai","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"Pt 4","key":"bib19","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/eye.1997.137","article-title":"Morphology of early choroidal neovascularisation in age-related macular degeneration: correlation with activity","volume":"11","author":"Sarks","year":"1997","journal-title":"Eye (Lond)"},{"key":"bib20","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.cmet.2013.03.009","article-title":"Impaired cholesterol efflux in senescent macrophages promotes age-related macular degeneration","volume":"17","author":"Sene","year":"2013","journal-title":"Cell Metab"},{"key":"bib21","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1001\/jamaophthalmol.2019.0010","article-title":"Association of CD11b+ Monocytes and Anti-Vascular Endothelial Growth Factor Injections in Treatment of Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy","volume":"137","author":"Subhi","year":"2019","journal-title":"JAMA Ophthalmol"},{"key":"bib22","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1001\/archopht.122.7.1013","article-title":"Monocyte activation in patients with age-related macular degeneration: a biomarker of risk for choroidal neovascularization?","volume":"122","author":"Cousins","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"bib23","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ebiom.2018.05.035","article-title":"Oxysterol Signatures Distinguish Age-Related Macular Degeneration from Physiologic Aging","volume":"32","author":"Lin","year":"2018","journal-title":"EBioMedicine"},{"key":"bib24","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.1016\/j.ophtha.2015.07.008","article-title":"The Onion Sign in Neovascular Age-Related Macular Degeneration Represents Cholesterol Crystals","volume":"122","author":"Pang","year":"2015","journal-title":"Ophthalmology"},{"key":"bib25","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.ophtha.2017.08.019","article-title":"Clinicopathologic Correlation of Anti-Vascular Endothelial Growth Factor-Treated Type 3 Neovascularization in Age-Related Macular Degeneration","volume":"125","author":"Li","year":"2018","journal-title":"Ophthalmology"},{"key":"bib26","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1159\/000342159","article-title":"Hyperreflective dots: a new spectral-domain optical coherence tomography entity for follow-up and prognosis in exudative age-related macular degeneration","volume":"229","author":"Coscas","year":"2013","journal-title":"Ophthalmologica"},{"key":"bib27","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1167\/iovs.06-0699","article-title":"Scavenger receptors for oxidized lipoprotein in age-related macular degeneration","volume":"48","author":"Kamei","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib28","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1001\/archopht.126.6.782","article-title":"Effect of bevacizumab on inflammation and proliferation in human choroidal neovascularization","volume":"126","author":"Tatar","year":"2008","journal-title":"Arch Ophthalmol"},{"key":"bib29","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/nature12166","article-title":"Control of angiogenesis by AIBP-mediated cholesterol efflux","volume":"498","author":"Fang","year":"2013","journal-title":"Nature"},{"issue":"5","key":"bib30","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1194\/jlr.M083618","article-title":"AIBP protects against metabolic abnormalities and atherosclerosis","volume":"59","author":"Schneider","year":"2018","journal-title":"J Lipid Res"},{"key":"bib31","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.atherosclerosis.2018.03.010","article-title":"AIBP reduces atherosclerosis by promoting reverse cholesterol transport and ameliorating inflammation in apoE-\/-mice","volume":"273","author":"Zhang","year":"2018","journal-title":"Atherosclerosis"},{"key":"bib32","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/s42003-020-1113-z","article-title":"Combination of apolipoprotein-A-I\/apolipoprotein-A-I binding protein and anti-VEGF treatment overcomes anti-VEGF resistance in choroidal neovascularization in mice","volume":"3","author":"Zhu","year":"2020","journal-title":"Commun Biol"},{"key":"bib33","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1016\/j.celrep.2018.04.110","article-title":"Inhibition of Neuroinflammation by AIBP: Spinal Effects upon Facilitated Pain States","volume":"23","author":"Woller","year":"2018","journal-title":"Cell Rep"},{"issue":"7","key":"bib34","doi-asserted-by":"publisher","first-page":"e20202059","DOI":"10.1084\/jem.20202059","article-title":"Normalization of cholesterol metabolism in spinal microglia alleviates neuropathic pain","volume":"218","author":"Navia-Pelaez","year":"2021","journal-title":"J Exp Med"},{"key":"bib35","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.ajo.2007.08.012","article-title":"Ranibizumab for predominantly classic neovascular age-related macular degeneration: subgroup analysis of first-year ANCHOR results","volume":"144","author":"Kaiser","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"bib36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.survophthal.2013.03.009","article-title":"Predictors of anti-VEGF treatment response in neovascular age-related macular degeneration","volume":"59","author":"Finger","year":"2014","journal-title":"Surv Ophthalmol"},{"key":"bib37","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.ophtha.2006.10.045","article-title":"Subgroup analysis of the MARINA study of ranibizumab in neovascular age-related macular degeneration","volume":"114","author":"Boyer","year":"2007","journal-title":"Ophthalmology"},{"key":"bib38","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1159\/issn.0250-3751","article-title":"Optical Coherence Tomography Angiography Study of Choroidal Neovascularization Early Response after Treatment","volume":"56","author":"Lumbroso","year":"2016","journal-title":"Dev Ophthalmol"},{"key":"bib39","doi-asserted-by":"publisher","first-page":"e0132643","DOI":"10.1371\/journal.pone.0132643","article-title":"Optimization of an Image-Guided Laser-Induced Choroidal Neovascularization Model in Mice","volume":"10","author":"Gong","year":"2015","journal-title":"PLoS One"},{"key":"bib40","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1016\/j.ajpath.2017.08.025","article-title":"Proteolytic Degradation and Inflammation Play Critical Roles in Polypoidal Choroidal Vasculopathy","volume":"187","author":"Kumar","year":"2017","journal-title":"Am J Pathol"},{"key":"bib41","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/0076-6879(86)28070-2","article-title":"Isolation and characterization of apolipoproteins A-I, A-II, and A-IV","volume":"128","author":"Brewer","year":"1986","journal-title":"Methods Enzymol"},{"key":"bib42","first-page":"1479","article-title":"A simple method for in vivo labelling of infiltrating leukocytes in the mouse retina using indocyanine green dye","volume":"8","author":"Sim","year":"2015","journal-title":"Dis Model Mech"},{"key":"bib43","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1038\/sj.gt.3302769","article-title":"EIAV vector-mediated delivery of endostatin or angiostatin inhibits angiogenesis and vascular hyperpermeability in experimental CNV","volume":"13","author":"Balaggan","year":"2006","journal-title":"Gene Ther"},{"key":"bib44","doi-asserted-by":"publisher","first-page":"3880","DOI":"10.1167\/iovs.10-6266","article-title":"In Vivo Evaluation of Laser-Induced Choroidal Neovascularization Using Spectral-Domain Optical Coherence Tomography","volume":"52","author":"Giani","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"131","key":"bib45","first-page":"56173","article-title":"In Vivo Multimodal Imaging and Analysis of Mouse Laser-Induced Choroidal Neovascularization Model","author":"Ragauskas","year":"2018","journal-title":"J Vis Exp"},{"key":"bib46","first-page":"e51061","article-title":"Detecting abnormalities in choroidal vasculature in a mouse model of age-related macular degeneration by time-course indocyanine green angiography","volume":"84","author":"Kumar","year":"2014","journal-title":"J Vis Exp"},{"key":"bib47","doi-asserted-by":"crossref","first-page":"3842","DOI":"10.1167\/iovs.13-13111","article-title":"Angiographic features of transgenic mice with increased expression of human serine protease HTRA1 in retinal pigment epithelium","volume":"55","author":"Kumar","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib48","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1161\/CIRCRESAHA.116.309754","article-title":"AIBP Limits Angiogenesis Through ?-Secretase-Mediated Upregulation of Notch Signaling","volume":"120","author":"Mao","year":"2017","journal-title":"Circ Res"},{"key":"bib49","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1167\/tvst.9.1.2","article-title":"In Vivo Measurement of the Human Vitreous Chamber Volume Using Computed Tomography Imaging of 100 Eyes","volume":"9","author":"Azhdam","year":"2020","journal-title":"Translational Vision Science & Technology"},{"key":"bib50","doi-asserted-by":"crossref","first-page":"4399","DOI":"10.1021\/acs.molpharmaceut.9b00679","article-title":"Intravitreal Pharmacokinetics in Mice: SPECT\/CT Imaging and Scaling to Rabbits and Humans","volume":"16","author":"Schmitt","year":"2019","journal-title":"Mol Pharm"},{"key":"bib51","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.exer.2019.01.009","article-title":"Secretogranin III as a novel target for the therapy of choroidal neovascularization","volume":"181","author":"LeBlanc","year":"2019","journal-title":"Exp Eye Res"},{"key":"bib52","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ophtha.2013.08.011","article-title":"Intravitreal aflibercept injection for neovascular age-related macular degeneration: ninety-six-week results of the VIEW studies","volume":"121","author":"Schmidt-Erfurth","year":"2014","journal-title":"Ophthalmology"},{"key":"bib53","first-page":"2355","article-title":"Aflibercept: a review of its use in the treatment of choroidal neovascularization due to age-related macular degeneration","volume":"9","author":"Balaratnasingam","year":"2015","journal-title":"Clin Ophthalmol"},{"key":"bib54","doi-asserted-by":"crossref","first-page":"109215","DOI":"10.1016\/j.exer.2022.109215","article-title":"Age differential response to bevacizumab therapy in choroidal neovascularization in rabbits","volume":"223","author":"Nguyen","year":"2022","journal-title":"Exp Eye Res"},{"key":"bib55","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1161\/hh2101.098613","article-title":"Role of ischemia and of hypoxia-inducible genes in arteriogenesis after femoral artery occlusion in the rabbit","volume":"89","author":"Deindl","year":"2001","journal-title":"Circ Res"},{"key":"bib56","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1159\/000189797","article-title":"The role of angiogenic growth factors in arteriogenesis","volume":"46","author":"Schierling","year":"2009","journal-title":"J Vasc Res"},{"key":"bib57","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s11010-010-0517-3","article-title":"Immunohistochemical study of the growth factors, aFGF, bFGF, PDGF-AB, VEGF-A and its receptor (Flk-1) during arteriogenesis","volume":"343","author":"Wu","year":"2010","journal-title":"Mol Cell Biochem"},{"key":"bib58","first-page":"121","article-title":"Arteriogenesis Versus Angiogenesis: Two Mechanisms of Vessel Growth","volume":"14","author":"Buschmann","year":"1999","journal-title":"News Physiol Sci"},{"key":"bib59","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1582-4934.2006.tb00290.x","article-title":"Arteriogenesis versus angiogenesis: similarities and differences","volume":"10","author":"Heil","year":"2006","journal-title":"J Cell Mol Med"},{"key":"bib60","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1172\/JCI119877","article-title":"Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb","volume":"101","author":"Arras","year":"1998","journal-title":"J Clin Invest"},{"key":"bib61","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.molmed.2012.06.007","article-title":"Regulation of collateral blood vessel development by the innate and adaptive immune system","volume":"18","author":"la Sala","year":"2012","journal-title":"Trends in Molec Med"},{"key":"bib62","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1084\/jem.20022027","article-title":"VEGF164-mediated inflammation is required for pathological, but not physiological, ischemia-induced retinal neovascularization","volume":"198","author":"Ishida","year":"2003","journal-title":"J Exp Med"},{"key":"bib63","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/jcp.22708","article-title":"Regulation of VEGF expression in human retinal cells by cytokines: implications for the role of inflammation in age-related macular degeneration","volume":"227","author":"Nagineni","year":"2012","journal-title":"J Cell Physiol"},{"key":"bib64","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/micc.12259","article-title":"Macrophages: An Inflammatory Link Between Angiogenesis and Lymphangiogenesis","volume":"23","author":"Corliss","year":"2016","journal-title":"Microcirculation"}],"container-title":["Investigative Opthalmology & Visual Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2783811","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:31:33Z","timestamp":1791927093000},"score":1,"resource":{"primary":{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2783811"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,1]]},"references-count":64,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,11,1]]}},"URL":"https:\/\/doi.org\/10.1167\/iovs.63.12.2","relation":{},"ISSN":["1552-5783"],"issn-type":[{"value":"1552-5783","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11,1]]}}}